Pantheon Vision Raises $2.5 Million in Seed Funding to Launch Development of Bioengineered Corneal Implant
Pantheon Vision, an early-stage ophthalmic medical device company, has announced $2.5 million in seed financing from Baltimore-based KeraLink International (KLI).
“We are thrilled to have KeraLink provide our initial funding to establish Pantheon Vision as a company dedicated to bringing groundbreaking ophthalmic innovations to patients worldwide,” expressed John Sheets, Ph.D., Chief Executive Officer of Pantheon Vision. “This funding enables us to advance our program to eradicate corneal blindness and restore vision.”
Photo courtesy of Photo courtesy of Amre.